HUE043518T2 - Függõség és impulzuskontroll zavarok kezelése PDE-7-inhibitorok alkalmazásával - Google Patents

Függõség és impulzuskontroll zavarok kezelése PDE-7-inhibitorok alkalmazásával

Info

Publication number
HUE043518T2
HUE043518T2 HUE13793319A HUE13793319A HUE043518T2 HU E043518 T2 HUE043518 T2 HU E043518T2 HU E13793319 A HUE13793319 A HU E13793319A HU E13793319 A HUE13793319 A HU E13793319A HU E043518 T2 HUE043518 T2 HU E043518T2
Authority
HU
Hungary
Prior art keywords
addiction
impulse
treatment
control disorders
pde7 inhibitors
Prior art date
Application number
HUE13793319A
Other languages
English (en)
Inventor
Gregory Demopulos
George Gaitanaris
Roberto Ciccocioppo
Original Assignee
Omeros Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/835,607 external-priority patent/US9220715B2/en
Application filed by Omeros Corp filed Critical Omeros Corp
Publication of HUE043518T2 publication Critical patent/HUE043518T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HUE13793319A 2012-05-07 2013-05-07 Függõség és impulzuskontroll zavarok kezelése PDE-7-inhibitorok alkalmazásával HUE043518T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261643611P 2012-05-07 2012-05-07
US13/835,607 US9220715B2 (en) 2010-11-08 2013-03-15 Treatment of addiction and impulse-control disorders using PDE7 inhibitors

Publications (1)

Publication Number Publication Date
HUE043518T2 true HUE043518T2 (hu) 2019-08-28

Family

ID=55442549

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13793319A HUE043518T2 (hu) 2012-05-07 2013-05-07 Függõség és impulzuskontroll zavarok kezelése PDE-7-inhibitorok alkalmazásával

Country Status (11)

Country Link
JP (4) JP2016138137A (hu)
CY (1) CY1121275T1 (hu)
DK (1) DK2846805T3 (hu)
ES (1) ES2711949T3 (hu)
HK (1) HK1208373A1 (hu)
HR (1) HRP20190279T1 (hu)
HU (1) HUE043518T2 (hu)
LT (1) LT2846805T (hu)
NZ (1) NZ628130A (hu)
PT (1) PT2846805T (hu)
RU (1) RU2665134C2 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2023027157A1 (hu) 2021-08-27 2023-03-02

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10148233A1 (de) * 2001-09-28 2003-04-10 Boehringer Ingelheim Pharma Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme
BRPI0616344A2 (pt) * 2005-09-26 2011-06-14 Avigen Inc mÉtodo para o tratamento de dependÊncia quÍmica e comportamental
US8637528B2 (en) * 2007-03-27 2014-01-28 Omeros Corporation Use of PDE7 inhibitors for the treatment of movement disorders
ES2533206T3 (es) * 2007-03-27 2015-04-08 Omeros Corporation Inhibidores de PDE7 para uso en el tratamiento de trastornos del movimiento
NZ580963A (en) * 2007-04-11 2012-08-31 Omeros Corp Compositions and methods for prophylaxis and treatment of addictions

Also Published As

Publication number Publication date
CY1121275T1 (el) 2020-05-29
JP2021138766A (ja) 2021-09-16
JP2019142980A (ja) 2019-08-29
JP6963431B2 (ja) 2021-11-10
DK2846805T3 (en) 2019-03-18
HK1208373A1 (en) 2016-03-04
RU2665134C2 (ru) 2018-08-28
JP2016138137A (ja) 2016-08-04
NZ628130A (en) 2017-02-24
ES2711949T3 (es) 2019-05-08
RU2014149192A (ru) 2016-07-10
LT2846805T (lt) 2019-02-25
JP2017171691A (ja) 2017-09-28
PT2846805T (pt) 2019-02-27
HRP20190279T1 (hr) 2019-04-05

Similar Documents

Publication Publication Date Title
IL261768B (en) Devices and methods for tissue treatment
EP2640395A4 (en) TREATMENT OF DISEASES ASSOCIATED WITH SEARCH AND PULSE CONTROL BY PDE7 INHIBITORS
HRP20171352T1 (hr) Wnt-antagonisti i postupci liječenja
HK1205938A1 (en) Inhibitors of human ezh2, and methods of use thereof ezh2
EP2887805A4 (en) COMPOUNDS AND METHOD FOR TREATING BLOOD HIGH PRESSURE
SG11201504022RA (en) Glutamase inhibitors and method of use
HK1207968A1 (en) Usp30 inhibitors and methods of use usp30
EP2844271A4 (en) PROCESSING METHOD AND AGENTS USEFUL THEREFOR
GB201217296D0 (en) Method of treatment and/or prevention
IL280144A (en) Use of telomerase inhibitors to treat bone marrow culture disorders and bone marrow culture tumors
EP2852397A4 (en) HUWENTOXIN IV VARIANTS AND METHODS OF USE
EP2694079A4 (en) POLYMERS AND METHOD FOR PAIN TREATMENT
EP2825173A4 (en) CALMODULIN INHIBITORS FOR THE TREATMENT OF RIBOSOMAL DISEASES AND RIBOSOMAPATHIES
HK1206282A1 (en) Tfpi inhibitors and methods of use tfpi
ZA201501503B (en) Bio-inoculant and use thereof for treatment of effluents
ZA201408055B (en) Compositions and methods for the treatment of local pain
RS58381B1 (sr) Lečenje zavisnosti i poremećaja kontrole impulsa upotrebom pde7 inhibitora
EP2681209A4 (en) COMPOUNDS AND METHODS FOR TREATING PAIN AND OTHER DISEASES
HRP20190279T1 (hr) Liječenje ovisnosti i poremećaja nagona pomoću pde7 inhibitora
EP2825184A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN
GB201101688D0 (en) Treatment of porous structire and device therefor